Last reviewed · How we verify
Kamada Anti-SARS-CoV-2
At a glance
| Generic name | Kamada Anti-SARS-CoV-2 |
|---|---|
| Sponsor | Kamada, Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |